Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marjan A Versnel

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Immunity|October 16, 2004
Id3 knockout mice as a new model for sjogren's syndrome: only a T cell defect or more?Marjan A Versnel
Journal of Clinical Medicine|February 5, 2021
Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren's SyndromeErika Huijser, Marjan A Versnel
Expert Review of Clinical Immunology|January 24, 2014
Type I IFN signature in primary Sjögren's syndrome patientsZana Brkic, Marjan A Versnel
Expert Review of Clinical Immunology|September 4, 2018
Interferon activation in primary Sjögren's syndrome: recent insights and future perspective as novel treatment targetIris L A Bodewes, Marjan A Versnel
Frontiers in Immunology|April 9, 2025
Advocating the role of trained immunity in the pathogenesis of ME/CFS: a mini reviewBart Humer, Willem A Dik, Marjan A Versnel
Arthritis Research & Therapy|July 4, 2015
The clinical relevance of animal models in Sjögren's syndrome: the interferon signature from mouse to manNaomi I Maria, Petra Vogelsang, Marjan A Versnel
Rheumatology (Oxford, England)|February 17, 2019
Innate immunity and interferons in the pathogenesis of Sjögren's syndromeIris L A Bodewes, Albin Björk, Marjan A Versnel, et al.
Frontiers in Immunology|June 29, 2026
Type I interferon pathway activation in connective tissue disease associated interstitial lung diseaseTobias M Defesche, Thomas Koudstaal, Marjan A Versnel, et al.
Arthritis Research & Therapy|June 21, 2008
Altered fractalkine cleavage potentially promotes local inflammation in NOD salivary glandManon E Wildenberg, Cornelia G van Helden-Meeuwsen, Hemmo A Drexhage, et al.
Rheumatology (Oxford, England)|May 23, 2025
Anti-mitochondrial antibodies as markers of disease activity in childhood-onset systemic lupus erythematosus: a longitudinal cohort studyMarina Barguil Macêdo, Mohamed Javad Wahadat, Albin Björk, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Immunity|October 16, 2004
Id3 knockout mice as a new model for sjogren's syndrome: only a T cell defect or more?Marjan A Versnel
Journal of Clinical Medicine|February 5, 2021
Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren's SyndromeErika Huijser, Marjan A Versnel
Expert Review of Clinical Immunology|January 24, 2014
Type I IFN signature in primary Sjögren's syndrome patientsZana Brkic, Marjan A Versnel
Expert Review of Clinical Immunology|September 4, 2018
Interferon activation in primary Sjögren's syndrome: recent insights and future perspective as novel treatment targetIris L A Bodewes, Marjan A Versnel
Frontiers in Immunology|April 9, 2025
Advocating the role of trained immunity in the pathogenesis of ME/CFS: a mini reviewBart Humer, Willem A Dik, Marjan A Versnel
Arthritis Research & Therapy|July 4, 2015
The clinical relevance of animal models in Sjögren's syndrome: the interferon signature from mouse to manNaomi I Maria, Petra Vogelsang, Marjan A Versnel
Rheumatology (Oxford, England)|February 17, 2019
Innate immunity and interferons in the pathogenesis of Sjögren's syndromeIris L A Bodewes, Albin Björk, Marjan A Versnel, et al.
Frontiers in Immunology|June 29, 2026
Type I interferon pathway activation in connective tissue disease associated interstitial lung diseaseTobias M Defesche, Thomas Koudstaal, Marjan A Versnel, et al.
Arthritis Research & Therapy|June 21, 2008
Altered fractalkine cleavage potentially promotes local inflammation in NOD salivary glandManon E Wildenberg, Cornelia G van Helden-Meeuwsen, Hemmo A Drexhage, et al.
Rheumatology (Oxford, England)|May 23, 2025
Anti-mitochondrial antibodies as markers of disease activity in childhood-onset systemic lupus erythematosus: a longitudinal cohort studyMarina Barguil Macêdo, Mohamed Javad Wahadat, Albin Björk, et al.
Pageof 8